Diabetes Mellitus, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Mechanisms of alpha1-adrenoceptor mediated QT prolongation in the diabetic rat heart.
|
19133277 |
2009 |
Diabetes Mellitus, Experimental
|
0.500 |
Biomarker
|
disease |
RGD |
Enhancement of methoxamine-induced contractile responses of rat ventricular muscle in streptozotocin-induced diabetes is associated with alpha1A adrenoceptor upregulation.
|
17054657 |
2007 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Proceeding investigations of G protein-coupled receptor (GPCR) heterocomplexes have demonstrated that the dopamine D2 receptor (D<sub>2</sub>R), one of the hub receptors in the physiology of schizophrenia, interacts with both the neurotensin NTS1 (NTS1R) and the serotonin 5-HT<sub>2A</sub> receptor (5-HT<sub>2A</sub>R) in cell lines and rodent brain tissue.
|
31704949 |
2019 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
A larger load of variants, involved in neurodevelopment, in combination with additional molecular events that affect sensory perception, olfactory transduction and G-protein-coupled receptor signaling may account for the development of 22q11.2DS-related SZ.
|
30710087 |
2019 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
G-protein-coupled receptor (GPCR) heterodimers are new targets for the treatment of schizophrenia.
|
29497362 |
2018 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
CX3CR1, a G protein-coupled receptor solely expressed by microglia in the brain, has been repeatedly reported to be associated with neurodevelopmental disorders including schizophrenia (SCZ) and autism spectrum disorders (ASD) in transcriptomic and animal studies but not in genetic studies.
|
28763059 |
2017 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Association of the ADRA1A gene and the severity of metabolic abnormalities in patients with schizophrenia.
|
22037178 |
2012 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
PSYGENET |
Family-based association analyses in EUC pedigrees and case-control analyses in AJ samples reveal significant associations for SNPs in and around DPYSL2 and ADRA1A, candidate genes previously associated with SZ in our work and others.
|
21302347 |
2011 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Reduced expression of G protein-coupled receptor kinases in schizophrenia but not in schizoaffective disorder.
|
21784156 |
2011 |
Schizophrenia
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Sex differences in the activity of signalling pathways and expression of G-protein-coupled receptor kinases in the neonatal ventral hippocampal lesion model of schizophrenia.
|
20158934 |
2011 |
Schizophrenia
|
0.400 |
Biomarker
|
disease |
BEFREE |
Family-based association analyses in EUC pedigrees and case-control analyses in AJ samples reveal significant associations for SNPs in and around DPYSL2 and ADRA1A, candidate genes previously associated with SZ in our work and others.
|
21302347 |
2011 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Further molecular dissection of the ADRA1A gene warrants better understanding on weight gain mechanisms in schizophrenia.
|
19918262 |
2010 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
These results suggest that the variants among the promoter of ADRA1A gene are unlikely to play a major role in the susceptibility to schizophrenia in the Chinese population.
|
17408692 |
2008 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We focused on one alpha(1)-adrenergic subtype, the alpha(1A)-adrenergic receptor, and proposed that genetic variants within the regulatory region of this gene (ADRA1A) alter the expression of this receptor, influencing susceptibility toward schizophrenia.
|
16043131 |
2005 |
Schizophrenia
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our result indicated that the alpha(1a)-adrenoceptor gene polymorphism investigated plays no major role in the pathogenesis of schizophrenia or in clozapine-induced urinary incontinence.
|
10940760 |
2000 |
Malignant neoplasm of breast
|
0.390 |
Biomarker
|
disease |
BEFREE |
G protein-coupled receptor 30 (GPR30), or G protein-coupled estrogen receptor (GPER), is a G protein-coupled receptor (GPCR) that is currently attracting considerable attention in breast cancer and cardiometabolic regulation.
|
30760632 |
2019 |
Malignant neoplasm of breast
|
0.390 |
Biomarker
|
disease |
BEFREE |
Leucine-rich repeat-containing G protein-coupled receptor (LGR) is known to participate in the occurrence and development of breast cancer by regulating the rebirth of tumor vessels.
|
26985934 |
2016 |
Malignant neoplasm of breast
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
G-protein-coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion.
|
24599592 |
2014 |
Malignant neoplasm of breast
|
0.390 |
Biomarker
|
disease |
BEFREE |
We recently reported that aberrant G-protein coupled receptor (GPCR) signaling promotes breast cancer metastasis by enhancing cancer cell migration and invasion.
|
23500535 |
2013 |
Malignant neoplasm of breast
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
The G protein-coupled receptor CCR2 was found to be elevated in breast cancers, correlating with CCL2 expression.
|
22927430 |
2012 |
Malignant neoplasm of breast
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Matrix metalloproteinase-1 (MMP-1) and G protein-coupled receptor, CXCR4, are elevated in these activated fibroblasts, in which they facilitate angiogenesis and matrix degradation, processes that are also vital to breast cancer metastasis.
|
19584257 |
2009 |
Malignant neoplasm of breast
|
0.390 |
Biomarker
|
disease |
BEFREE |
Together, these studies reveal the novel findings that PAR2, a second protease-activated G protein-coupled receptor, has a critical role in breast cancer cell migration and invasion and functions as the endogenous receptor for coagulant proteases VIIa and Xa in these cells.
|
16397244 |
2006 |
Malignant neoplasm of breast
|
0.390 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer.
|
11897506 |
2002 |
Malignant neoplasm of breast
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.
|
9367686 |
1997 |
Malignant neoplasm of breast
|
0.390 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|